These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 29753698)

  • 1. Hematopoietic stem cell transplantation in geriatric patients in Turkey.
    Goker H; Kelkitli E; Buyukasik Y; Demiroğlu H
    Transfus Apher Sci; 2018 Apr; 57(2):159-162. PubMed ID: 29753698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What the internist should know about stem cell transplant in the elderly patient.
    Medinger M; Passweg J
    Eur J Intern Med; 2018 Dec; 58():43-47. PubMed ID: 29960832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Progress of research on allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimen for treatment of myelodysplastic syndrome - review].
    Zhang Z; Li X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):969-74. PubMed ID: 18718102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning.
    Servais S; Baron F; Beguin Y
    Transfus Apher Sci; 2011 Apr; 44(2):205-10. PubMed ID: 21345734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal Toxicity, Systemic Inflammation, and Liver Biochemistry in Allogeneic Hematopoietic Stem Cell Transplantation.
    Jordan K; Pontoppidan P; Uhlving HH; Kielsen K; Burrin DG; Weischendorff S; Christensen IJ; Jørgensen MH; Heilmann C; Sengeløv H; Müller K
    Biol Blood Marrow Transplant; 2017 Jul; 23(7):1170-1176. PubMed ID: 28344059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of immune reconstitution status in recipients of a successful hematopoietic stem cell transplant from peripheral blood after reduced intensity conditioning.
    Jaime-Pérez JC; Villarreal-Villarreal CD; Méndez-Ramírez N; Vázquez-Garza E; Salazar-Riojas R; Gómez-Almaguer D
    Blood Cells Mol Dis; 2016 May; 58():52-6. PubMed ID: 27067489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9-modified hematopoietic stem cells-present and future perspectives for stem cell transplantation.
    Daniel-Moreno A; Lamsfus-Calle A; Raju J; Antony JS; Handgretinger R; Mezger M
    Bone Marrow Transplant; 2019 Dec; 54(12):1940-1950. PubMed ID: 30903024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age does not matter: Mobilization and harvesting are safe and effective for elderly allogeneic peripheral hematopoietic stem cell donors.
    Ocakci S; Kahraman S; Cagirgan S
    Transfus Apher Sci; 2017 Dec; 56(6):825-828. PubMed ID: 29153310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations.
    Atilla E; Ataca Atilla P; Demirer T
    Balkan Med J; 2017 Jan; 34(1):1-9. PubMed ID: 28251017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and risk factors for hepatic sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: A retrospective multicenter study of Turkish hematology research and education group (ThREG).
    Soyer N; Gunduz M; Tekgunduz E; Deveci B; Ozdogu H; Sahin HH; Turak EE; Okay M; Kuku I; Hindilerden IY; Topcuoglu P; Altuntas F; Karadogan I; Pehlivan M; Unal A; Goker H; Erkurt MA; Besısık SK; Vural F;
    Transfus Apher Sci; 2020 Aug; 59(4):102827. PubMed ID: 32522474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonmyeloablative allogeneic hematopoietic stem cell transplantation.
    Baron F; Beguin Y
    J Hematother Stem Cell Res; 2002 Apr; 11(2):243-63. PubMed ID: 11983097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion policy in allogeneic hematopoietic stem cell transplantation.
    Topcuoglu P
    Transfus Apher Sci; 2018 Apr; 57(2):174-177. PubMed ID: 29724631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second allogeneic hematopoietic stem cell transplantation in children with severe aplastic anemia.
    Kudo K; Muramatsu H; Yoshida N; Kobayashi R; Yabe H; Tabuchi K; Kato K; Koh K; Takahashi Y; Hashii Y; Kawano Y; Inoue M; Cho Y; Sakamaki H; Kawa K; Kato K; Suzuki R; Kojima S
    Bone Marrow Transplant; 2015 Oct; 50(10):1312-5. PubMed ID: 26121106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells.
    Cieri N; Greco R; Crucitti L; Morelli M; Giglio F; Levati G; Assanelli A; Carrabba MG; Bellio L; Milani R; Lorentino F; Stanghellini MT; De Freitas T; Marktel S; Bernardi M; Corti C; Vago L; Bonini C; Ciceri F; Peccatori J
    Biol Blood Marrow Transplant; 2015 Aug; 21(8):1506-14. PubMed ID: 26001696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Allogeneic hematopoietic stem cell transplantation in elderly].
    Castagna L; Blaise D; Furst S
    Bull Cancer; 2011 Aug; 98(8):915-25. PubMed ID: 21835732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favorable outcome in children and adolescents with a high proportion of advanced phase disease using single/multiple autologous or matched/mismatched allogeneic stem cell transplantations.
    Niederwieser C; Starke S; Fischer L; Krahl R; Beck J; Gruhn B; Ebell W; Körholz D; Wößmann W; Bader P; Lang P; Al-Ali HK; Cross M; Eisfeld AK; Heyn S; Vucinic V; Franke GN; Lange T; Pönisch W; Behre G; Christiansen H
    Ann Hematol; 2016 Feb; 95(3):473-81. PubMed ID: 26696465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioning.
    Yucel OK; Saliba RM; Rondon G; Ahmed S; Alousi A; Bashir Q; Ciurea SO; Popat U; Khouri I; Marin D; Rezvani K; Kebriaei P; Shpall EJ; Champlin RE; Oran B
    Cancer; 2017 Jul; 123(14):2661-2670. PubMed ID: 28324640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective Study of Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome-Positive Leukemia: 25 Years' Experience at Gustave Roussy Cancer Campus.
    Chamseddine AN; Willekens C; De Botton S; Bourhis JH
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S129-40. PubMed ID: 26297265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful Allogeneic Hematopoietic Stem Cell Transplantation in XIAP Deficiency Using Reduced-Intensity Conditioning.
    Chellapandian D; Krueger J; Schechter T; Gassas A; Weitzman S; Naqvi A; Ali M
    Pediatr Blood Cancer; 2016 Feb; 63(2):355-7. PubMed ID: 26398727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor-derived constitutional chromosomal abnormalities after allogeneic hematopoietic cell transplantation: a single-center experience and a review of the literature.
    Nishihori T; El-Asmar J; Shah B; Hussaini M; Komrokji R; List A; Anasetti C; Kharfan-Dabaja MA
    Bone Marrow Transplant; 2015 Oct; 50(10):1388-92. PubMed ID: 26191951
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.